ATNM vs TDG · rev $35.0M vs P/E 41, rev $8.83B
Actinium Pharmaceuticals Inc (ATNM) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ATNM currently screens at market cap $33.9M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ATNM and TDG stock pages for the full models.
Not investment advice.